menu search

Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy

Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...

October 5, 2023, 3:00 pm

European patent office to grant zyversa therapeutics’ patent application for cholesterol transport mediator™ var 200 for use in patients with diabetic nephropathy/diabetic kidney disease

Cholesterol Transport Mediator™ VAR 200 is in development to reduce renal cholesterol and lipid accumulation that damages the kidneys’ filtration ...

June 6, 2023, 1:07 pm

Travere therapeutics stock slides 35% after announcing disappointing results from 2-year trial of kidney drug

Travere Therapeutics Inc.'s stock TVTX tumbled 35% Tuesday, after the company said data from a two-year study of a kidney drug failed to show a statis...

May 2, 2023, 12:50 pm

Travere therapeutics announces topline results from two-year primary efficacy endpoint in pivotal phase 3 duplex study of sparsentan in focal segmental glomerulosclerosis

The DUPLEX Study did not achieve the primary efficacy eGFR slope endpoint over 108 weeks of treatment Secondary and topline exploratory endpoints tren...

May 1, 2023, 8:05 pm

Point focal shares markets insights with broardridge's nyfix platform

Broadridge Financial Solutions, Inc. (Broadridge), the global ...

February 6, 2023, 2:04 pm

Angion biomedica pulls the plug on another kidney disease trial - read why

Angion Biomedica Corp (NASDAQ: ANGN) has discontinued the JUNIPER Phase 2 trial of ANG-3070, an oral tyrosine kinase inhibitor, in primary proteinu...

June 30, 2022, 6:11 am

Cardiovascular systems, orbusneich scores fda approval for scoreflex scoring balloon

Cardiovascular Systems Inc (NASDAQ: CSII), along with OrbusNeich Medical Company Ltd, have received FDA PMA approval for OrbusNeich's Scoreflex N...

January 20, 2022, 8:51 am

Cardiovascular systems, orbusneich scores fda approval for scoreflex scoring balloon

Cardiovascular Systems Inc (NASDAQ: CSII), along with OrbusNeich Medical Company Ltd, have received FDA PMA approval for OrbusNeich's Scoreflex N...

January 20, 2022, 8:51 am

Cardiovascular systems, orbusneich scores fda approval for scoreflex scoring balloon

Cardiovascular Systems Inc (NASDAQ: CSII), along with OrbusNeich Medical Company Ltd, have received FDA PMA approval for OrbusNeich's Scoreflex N...

January 20, 2022, 8:51 am


Search within

Pages Search Results: